180 Life Sciences Corp. (ATNF) DCF Valuation

180 Life Sciences Corp. (ATNF) DCF Valuation

US | Healthcare | Biotechnology | NASDAQ
180 Life Sciences Corp. (ATNF) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

180 Life Sciences Corp. (ATNF) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify 180 Life Sciences Corp. (ATNF) valuation with this customizable DCF Calculator! Featuring real 180 Life Sciences Corp. (ATNF) financials and adjustable forecast inputs, you can test scenarios and uncover 180 Life Sciences Corp. (ATNF) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -20.8 -5.5 -20.0 -17.8 -22.1 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .1 .1 .1 .1 .1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -20.9 -5.6 -20.2 -17.9 -22.2 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .1 2.1 8.2 7.0 2.0 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .3 1.1 2.2 -.6 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 4.1 8.5 .6 1.8 2.2 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.1 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 10.54 10.54 10.54 10.54 10.54 10.54 10.54 10.54 10.54 10.54
EBITAT -20.9 -6.2 -20.1 -17.5 -19.9 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -17.1 -2.5 -29.1 -13.3 -20.1 -2.2 .0 .0 .0 .0
WACC, % 4.96 4.96 4.96 4.9 4.69 4.89 4.89 4.89 4.89 4.89
PV UFCF
SUM PV UFCF -2.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -1
Equity Value -1
Diluted Shares Outstanding, MM 0
Equity Value Per Share -3.00

What You Will Get

  • Real ATNF Financial Data: Pre-filled with 180 Life Sciences Corp.'s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See 180 Life Sciences Corp.'s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Customizable Research Parameters: Adjust essential inputs such as market growth rates, clinical trial phases, and R&D expenditures.
  • Instant DCF Valuation: Quickly computes intrinsic value, net present value (NPV), and additional financial metrics.
  • High-Precision Accuracy: Incorporates 180 Life Sciences Corp.'s (ATNF) actual financial data for credible valuation results.
  • Simplified Scenario Analysis: Easily explore various assumptions and assess their impacts on outcomes.
  • Efficiency Booster: Streamlines the valuation process, removing the necessity for intricate model development from the ground up.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered 180 Life Sciences Corp. (ATNF) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for 180 Life Sciences Corp. (ATNF)’s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose 180 Life Sciences Corp. (ATNF) Calculator?

  • Accuracy: Leverages real financial data from 180 Life Sciences Corp. for precise calculations.
  • Flexibility: Tailored for users to easily adjust and experiment with various inputs.
  • Time-Saving: Eliminate the complexities of creating a financial model from the ground up.
  • Professional-Grade: Crafted with the expertise and precision expected by industry leaders.
  • User-Friendly: Intuitive interface suitable for users of all financial backgrounds.

Who Should Use This Product?

  • Healthcare Professionals: Understand advanced treatment methodologies and apply them using real-world case studies.
  • Researchers: Integrate innovative approaches into studies or clinical trials.
  • Investors: Evaluate your investment strategies and analyze valuation projections for 180 Life Sciences Corp. (ATNF).
  • Analysts: Enhance your analysis with a customizable financial model tailored for biotech firms.
  • Entrepreneurs: Discover how biotech companies like 180 Life Sciences Corp. (ATNF) are assessed in the market.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled 180 Life Sciences Corp. (ATNF) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for 180 Life Sciences Corp. (ATNF).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.